Recruiting ESCRT to single-chain heterotrimer peptide MHCI releases antigen-presenting vesicles that stimulate T cells selectively

B Blade A. Olson (Division of Biology and Biological Engineering, California Institute of Technology) K Kathryn E. Huey-Tubman (Division of Biology and Biological Engineering, California Institute of Technology) Z Zhiyuan Mao (Department of Molecular and Medical Pharmacology, University of California) M Magnus A. G. Hoffmann (Division of Biology and Biological Engineering, California Institute of Technology) P Pamela J. Bjorkman (Division of Biology and Biological Engineering, California Institute of Technology, Pasadena, CA, USA.) R Richard M. Murray (Division of Biology and Biological Engineering, California Institute of Technology) S Stephen L. Mayo (Division of Biology and Biological Engineering, California Institute of Technology)

Abstract

Immune cells naturally secrete extracellular antigen-presenting vesicles (APVs) displaying peptide:MHC complexes to facilitate the initiation, expansion, maintenance, or silencing of immune responses. Previous work has sought to manufacture and purify these vesicles for cell-free immunotherapies. In this study, APV assembly and release is achieved in nonimmune cells by transfecting a single-chain heterotrimer (SCT) peptide major histocompatibility complex I (pMHCI) construct containing an ESCRT- and ALIX-binding region (EABR) sequence appended to the cytoplasmic tail; this EABR sequence recruits ESCRT proteins to induce the budding of APVs displaying SCT pMHCI. A comparison of multiple pMHCI constructs shows that inducing the release of APVs by the addition of an EABR sequence generalizes across SCT pMHCI constructs. Purified pMHCI/EABR APVs selectively stimulate IFN-γ release from T cells presenting their cognate T cell receptor, demonstrating the potential use of these vesicles as a form of cell-free immunotherapy.

Article Details

Volume / Issue Vol. 122, Issue 51
Published December 23, 2025
ISSN 0027-8424
Publisher National Academy of Sciences

Authors (7)

B

Blade A. Olson

Division of Biology and Biological Engineering, California Institute of Technology

K

Kathryn E. Huey-Tubman

Division of Biology and Biological Engineering, California Institute of Technology

Z

Zhiyuan Mao

Department of Molecular and Medical Pharmacology, University of California

M

Magnus A. G. Hoffmann

Division of Biology and Biological Engineering, California Institute of Technology

P

Pamela J. Bjorkman

Division of Biology and Biological Engineering, California Institute of Technology, Pasadena, CA, USA.

R

Richard M. Murray

Division of Biology and Biological Engineering, California Institute of Technology

S

Stephen L. Mayo

Division of Biology and Biological Engineering, California Institute of Technology